{"id":"W1969461242","doi":"10.1080/10428190801993470","title":"Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group","year":2008,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Rituximab; DHAP; Chemotherapy; Oncology; Internal medicine; Lymphoma; Hodgkin lymphoma; Salvage therapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001427412,0.0005891518,0.001528119,0.0002627739,0.0002861793,0.0004830732,0.0007666236,0.0006600837,0.001966476],"category_scores_gemma":[0.0007060129,0.0003463779,0.0005024811,0.0004088249,0.0007019804,0.0004258277,0.0003227342,0.001452513,0.0004615108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008377116,"about_ca_system_score_gemma":0.001404305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001716325,"about_ca_topic_score_gemma":0.008873716,"domain_scores_codex":[0.9994978,0.0003724215,0.00001310441,0.0000480663,0.00003173543,0.00003693394],"domain_scores_gemma":[0.9994862,0.0001172467,0.0001038484,0.00005014671,0.000038225,0.0002042788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5731759,0.02219782,0.01706963,0.00128398,0.001697871,0.0006489629,0.0005639595,0.003129392,0.02717891,0.0002793674,0.005449627,0.3473246],"study_design_scores_gemma":[0.6271707,0.3186868,0.04041859,0.0001484964,0.0007968068,0.0008672148,0.0001663911,0.001522973,0.00247876,0.0002311051,0.007484565,0.00002754225],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926156,0.004951497,0.0002012844,0.0003567586,0.00005216408,0.0006312128,0.0001277136,0.00004199973,0.001021853],"genre_scores_gemma":[0.9871022,0.005079083,0.002174154,0.0008838795,0.0001580753,0.001648173,0.0007581334,0.00002087805,0.002175417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001966476,"threshold_uncertainty_score":0.007548988,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01807630526565046,"score_gpt":0.2722127211316742,"score_spread":0.2541364158660237,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}